On Thursday, the US Food and Drug Administration (FDA) approved AquaBounty's new Animal Drug Application for the production, sale, and consumption of its AquAdvantage Salmon, an Atlantic salmon that has been genetically enhanced to reach market size in less time than conventional farmed Atlantic salmon.
“The FDA has thoroughly analyzed and evaluated the data and information submitted by AquaBounty Technologies regarding AquAdvantage Salmon and determined that they have met the regulatory requirements for approval, including that food from the fish is safe to eat,” said Bernadette Dunham, director of the FDA’s Center for Veterinary Medicine.
Click here for a Q&A explaining today's approval of GM salmon from AquaBounty.
The
